As of Jul 02
| -0.07 / -0.81%|
The 8 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 24.00 and a low estimate of 8.00. The median estimate represents a +98.14% increase from the last price of 8.58.
The current consensus among 9 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.